Harry Carothers Wiess Professor & Chair of Otolaryngology-HNS
University of Texas Medical Branch Dept of Otolaryngolgy
Galveston, TX, United States
Nausheen Jamal received her MD from the Baylor College of Medicine in Houston, TX. She completed her residency in Otolaryngology-Head & Neck Surgery at Albert Einstein College of Medicine in New York City, followed by a two-year fellowship in Laryngology at the University of California, Los Angeles. She received her MBA from the Kellogg School of Management at Northwestern University. She currently serves as Professor & the Harry Carothers Wiess Chair of the Department of Otolaryngology-Head & Neck Surgery at the the University of Texas Medical Branch, John Sealy School of Medicine in Galveston, TX.
Cutting Edge Feedback: Framework for Feedback Following Surgical Procedures
Saturday, October 17, 2026
9:30 AM - 10:30 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Pregnancy Disclosure Among Trainees: How to Create a Culture of Trust
Saturday, October 17, 2026
4:00 PM - 5:00 PM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Near Misses, Never Events, and Just Plain Scary Cases
Sunday, October 18, 2026
8:00 AM - 9:00 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Psychological Safety for Surgeons: Building Trust, Teamwork, and Well-being
Sunday, October 18, 2026
9:30 AM - 10:30 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Monday, October 19, 2026
8:00 AM - 9:00 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Annual Meeting Program Committee
Monday, October 19, 2026
2:30 PM - 3:30 PM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.